Opening Keynote Presentation
Sunday, October 31
1:30 p.m. – 3:00 p.m. PDT
Eric Topol is the Founder and Director of the Scripps Research Translational Institute, Professor, Molecular Medicine, and Executive Vice-President of Scripps Research. As a researcher, he has published more than 1,200 peer-reviewed articles, with more than 310,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine. His principal scientific focus has been on the genomic and digital tools to individualize medicine.
In 2016, Topol was awarded a $207 million grant from the National Institutes of Health (NIH) to lead a significant part of the Precision Medicine (All of Us) Initiative, a prospective research program enrolling one million participants in the U.S. This is in addition to his role as principal investigator for a flagship $35M NIH grant to promote innovation in medicine. He was the founder of a new medical school at Cleveland Clinic, Lerner College of Medicine, with Case Western University. He has more than 440,000 followers on Twitter where recently he has been reporting insights and research findings for COVID-19. Besides editing several textbooks, he has published three bestseller books on the future of medicine: The Creative Destruction of Medicine, The Patient Will See You Now, and Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. Lastly, Topol was commissioned by the UK 2018-2019 to lead planning for the National Health Service’s integration of AI and new technologies.
Closing Keynote Presentation
Wednesday, November 3
12:45 p.m. – 1:30 p.m. PDT
Irene Dankwa-Mullan, MD, MPH is a nationally recognized physician, researcher and industry thought leader working at the intersection of healthcare, health equity, public health, informatics, data science and applied artificial intelligence. She serves as the Chief Health Equity Officer and Deputy Chief Health Officer at IBM Watson Health, IBM Corporation and a member of the IBM Industry Academy, comprised of eminent and industry visionaries to help shape the global IBM agenda. As Chief Health Equity Officer, she works across business market segments to promote a culture of health equity, social justice, ethical AI, diversity and inclusion, and to promote technology for social good. Her responsibilities as Deputy Chief Health Officer includes leadership for evaluation research and implementation science and promoting opportunities to advance the science of AI and advanced analytics.
Dr. Dankwa-Mullan spent nearly a decade delivering and managing front-line primary care, preventive services, and community-based research in cancer prevention and care as both a primary care physician and Medical Director. Most recently, she served as a Medical Officer and Deputy Director for extramural scientific programs at the National Institutes on Minority Health and Health Disparities, NIH. While at the NIH, she was an active member on many key strategic boards and committees, including many that were cross-sectoral and transdisciplinary. Dankwa-Mullan was selected to initiate and coordinate the NIH efforts in a transformational research agenda to advance the science of health disparities research in a deliberate and inclusive engagement process involving the NIH, community partners and the broader scientific community. She is the lead scientific editor of the first authoritative resource textbook ‘The Science of Health Disparities Research’ designed to help researchers and the healthcare community identify research questions, design and conduct studies with culturally appropriate interventions, and advance science while proposing solutions and improving health.